SCOPUS 정보 검색 플랫폼

Dermatologic Therapy

Volumn 25, Issue 6, 2012, Pages 619-620

Kaposi's sarcoma associated with treatment with adalimumab

(4) Amadu, Valentina a Satta, Rosanna a Montesu, Maria Antonietta a Cottoni, Francesca a

a UNIVERSITY OF SASSARI (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOSPORIN; HEMOSIDERIN; LEFLUNOMIDE; METHYLPREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; CELL PROLIFERATION; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; MALE; MEDICAL HISTORY; RHEUMATOID ARTHRITIS;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FOOT DISEASES; HUMANS; MALE; MIDDLE AGED; SARCOMA, KAPOSI; TIME FACTORS; TOES;

EID: 84870482191 PISSN: 13960296 EISSN: 15298019 Source Type: Journal
DOI: 10.1111/j.1529-8019.2012.01523.x Document Type: Article

Times cited : (12)

References (5)

1
- 33646696885
- Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
- DOI 10.1001/jama.295.19.2275
- Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V,. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006: 295: 2275-2285. (Pubitemid 43736578)
- (2006) Journal of the American Medical Association , vol.295 , Issue.19 , pp. 2275-2285
- Bongartz, T.¹ Sutton, A.J.² Sweeting, M.J.³ Buchan, I.⁴ Matteson, E.L.⁵ Montori, V.⁶

2
- 33747008410
- Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumour necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register
- Dixon WG, Watson K, Lunt M, et al. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 2006: 54: 2-368.
- (2006) Arthritis Rheum , vol.54 , pp. 2-368
- Dixon, W.G.¹ Watson, K.² Lunt, M.³

3
- 0038546761
- Kaposi's sarcoma associated with tumour necrosis factor α neutralising therapy [4]
- DOI 10.1136/ard.62.7.684
- Cohen CD, Horster S, Sander CA, Bogner JR,. Kaposi's sarcoma associated with tumour necrosis factor alpha neutralising therapy. Ann Rheum Dis 2003: 62: 684. (Pubitemid 36760574)
- (2003) Annals of the Rheumatic Diseases , vol.62 , Issue.7 , pp. 684
- Cohen, C.D.¹ Horster, S.² Sander, C.A.³ Bogner, J.R.⁴

4
- 77957361603
- Kaposi sarcoma associated with infliximab treatment
- Martínez-Martínez ML, Pérez-García LJ, Escario-Travesedo E, Ribera-Vaquerizo PA,. Kaposi sarcoma associated with infliximab treatment. Actas Dermosifiliogr 2010: 101: 462-464.
- (2010) Actas Dermosifiliogr , vol.101 , pp. 462-464
- Martínez-Martínez, M.L.¹ Pérez-García, L.J.² Escario-Travesedo, E.³ Ribera-Vaquerizo, P.A.⁴

5
- 71249097290
- Kaposi's disease in a patient on adalimumab for rheumatoid arthritis
- Bret J, Hernandez J, Aquilina C, Zabraniecki L, Fournie B,. Kaposi's disease in a patient on adalimumab for rheumatoid arthritis. Joint Bone Spine 2009: 76: 721-722.
- (2009) Joint Bone Spine , vol.76 , pp. 721-722
- Bret, J.¹ Hernandez, J.² Aquilina, C.³ Zabraniecki, L.⁴ Fournie, B.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.